Evogene Ltd Company Profile
NASDAQ: EVGNIndustrialsAgricultural ChemicalsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Evogene at a glance
Evogene Ltd (NASDAQ: EVGN) is a Agricultural Chemicals company in the Industrials sector headquartered in Rehovot, Israel. Evogene is led by Mr. Ofer Haviv CPA and employs about 38 people. At a market capitalization of $5.7 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001574565, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Evogene do?
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD); and with ELEO, Inc. to develop oral small-molecule inhibitors targeting the PCSK9 pathway for the treatment of hyperlipidemia and cardiovascular diseases. The company was incorporated in 1999 and is headquartered in Rehovot, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- Evogene Ltd
- Ticker
- NASDAQ: EVGN
- Sector
- Industrials
- Industry
- Agricultural Chemicals
- CEO
- Mr. Ofer Haviv CPA
- Employees
- 38
- Headquarters
- 13 Gad Feinstein Street, Rehovot, Israel
- Phone
- 972 8 931 1900
- Website
- evogene.com
- Market cap
- $5.71M
- SEC CIK
- 0001574565
Companies similar to Evogene
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SNESSenesTech Inc. | 0.69 | +6.15% | $4.71M | vs EVGN |
| FRTTFort Technology Inc. | 0.47 | -9.79% | $7.14M | vs EVGN |
| NXTSNexentis Technologies Inc. | 1.58 | -7.06% | $1.05M | vs EVGN |
| BIOXBioceres Crop Solutions Corp. | 0.173 | -5.41% | $11.04M | vs EVGN |
| ICLICL Group Ltd. | 4.08 | -1.45% | — | vs EVGN |
| UANCVR Partners LP | 95.09 | -0.88% | — | vs EVGN |
| AVDAmerican Vanguard Corporation | 0.68 | -1.48% | $20.10M | vs EVGN |
| CBUSCibus Inc. Class A | 1.21 | -1.63% | $92.73M | vs EVGN |